glenmark pharmaceuticals pms study

Favipiravir: PMS study finds no issues with the usage, mild side effects detected–here’s why it was removed from the covid treatment

Health September 19, 2021

A total quantity of 1,083 patients took portion in the multicenter, open-label single-arm study and the study showed no issues…